(Q34733963)

4 August 2017

1 reference

title

Prognostic biomarkers in resected colorectal cancer: implications for adjuvant chemotherapy (English)

1 reference

4 August 2017

0 references

1 reference

1 reference

1 reference

Graziano F

1

1 reference

4 August 2017

Catalano V

series ordinal

2

1 reference

4 August 2017

Baldelli AM

series ordinal

3

1 reference

4 August 2017

Cascinu S

series ordinal

4

1 reference

4 August 2017

publication date

1 August 2001

1 reference

Expert Review of Anticancer Therapy

4 August 2017

published in

1 reference

4 August 2017

volume

1

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

247-257

1 reference

Tumour markers of prognosis in colorectal cancer

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

The p53-mdm-2 autoregulatory feedback loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

Prognostic significance of p53 expression, chromosome 17 copy number, and DNA ploidy in non-metastasized colorectal carcinomas (stages IB and II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

Identification of a chromosome 18q gene that is altered in colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

The DCC protein and prognosis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

Molecular predictors of survival after adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

Molecular prognostic markers and colorectal cancer: the search goes on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

Molecular Markers of Prognosis in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

Adjuvant chemotherapy for stage II (Dukes» B) colon cancer:too early for routine use

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.247

21 January 2018

Identifiers

DOI

10.1586/14737140.1.2.247

1 reference

4 August 2017

1 reference